HEPCLUDEX 2 mg powder for solution for injection, VIR-2218, VIR-3434
VIR-CHDV-V206
Phase 2 small_molecule active
Quick answer
HEPCLUDEX 2 mg powder for solution for injection, VIR-2218, VIR-3434 for Chronic Hepatitis D Virus (HDV) Infection is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Chronic Hepatitis D Virus (HDV) Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active